Please login to the form below

Not currently logged in
Email:
Password:

Theravance hires BMS veteran Pasqualone

He joins as senior VP, operations

Theravance has named Frank Pasqualone as senior VP, operations.

Pasqualone joins the US-based biopharma from Bristol-Myers Squibb (BMS) where he most recently served as president of the intercontinental region, including Latin America, the Middle East and Africa.

He spent 25 years at BMS, where his roles included present of southern Europe and head of the company's US oncology/virology business. He also led diabetes marketing in the US at one stage.

Pasqualone joins Theravance as the company at a crucial time as its development deals with GlaxoSmithKline bears fruit with US approval of respiratory treatment Anoro Ellipta.

This followed the approval last year of Theravance's antibiotic Vibativ (telavancin) to treat a hospital-acquired lung infection.

Since then, the company has been strengthening its senior business team, a process that has included the appointment of Jeff Jonker as senior VP, corporate and business development.

27th January 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
ben.quarless@publicishealth.com

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics